Latest DEF 14A proxy statements

Atlassian Corporation has filed definitive additional proxy materials with the SEC, indicating no fee is required.

Glucotrack, Inc. issued a reminder to stockholders to cast their votes for the upcoming Special Meeting scheduled for October 31, 2025.

SRH Total Return Fund, Inc. announces its Annual Meeting of Stockholders for November 13, 2025, to elect Class I Directors and address other business.

Atlassian Corporation announces its 2025 Annual Meeting of Stockholders, seeking approval for director elections, auditor ratification, executive compensation, and significant amendments to its share incentive and employee share purchase plans.

Healthcare Triangle, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 7, 2025, to elect directors and ratify its independent auditor.

DT Cloud Star Acquisition Corporation has further adjourned its annual general meeting to October 20, 2025, allowing shareholders more time to vote or withdraw redemption requests.

TrueCar, Inc. has entered into a definitive agreement to be acquired by Fair Holdings, Inc., led by founder Scott Painter, in an all-cash transaction valued at approximately $227 million, taking the company private.

Hillenbrand, Inc. announced a definitive agreement to be acquired by an affiliate of Lone Star Funds for $32.00 per share, valuing the company at approximately $3.8 billion.

Lunai Bioworks, Inc. will hold its 2025 Annual Meeting to vote on key governance matters, including an expanded equity incentive plan, as the company navigates significant net losses and recent dilutive debt restructuring.

Ferguson Enterprises Inc. announces the availability of proxy materials and details for its 2025 Annual Meeting of Stockholders, scheduled for December 3, 2025.

Marathon Bancorp, Inc. announced its 2025 Annual Meeting of Stockholders for November 18, 2025, to elect directors and ratify its independent auditor.

Moderna is seeking shareholder approval for a one-time stock option exchange program designed to retain non-Executive Committee employees by addressing significantly underwater stock options.

Ferguson Enterprises Inc. reported strong fiscal year 2025 performance with increased net sales and adjusted diluted EPS, while announcing a change in its fiscal year end to December 31st.

Mountain Crest Acquisition Corp. V is seeking stockholder approval to extend its business combination deadline to November 16, 2026, to finalize its merger with CUBEBIO Co., Ltd.

Cineverse Corp. is seeking stockholder approval for key proposals at its upcoming virtual annual meeting, including the election of directors, executive compensation, and a significant increase in its equity incentive plan shares.

Benitec Biopharma Inc. announced the details for its Annual Stockholder Meeting on December 1, 2025, including director elections and key proposals.

Seagate Technology Holdings plc filed an amendment to its definitive proxy statement, revising executive severance payment details and beneficial ownership information for its Chief Commercial Officer and Chief Financial Officer.

Tesla is soliciting shareholder votes for its 2025 Annual Meeting, emphasizing the re-election of Class III directors and approval of the 2025 CEO Performance Award to secure future growth.

Healthcare Triangle, Inc. announces the acquisition of Niyama Healthcare's cloud and technology assets and Ezovion Solutions, expanding its global healthcare IT footprint.

Heidrick & Struggles reassures employees on compensation, benefits, and growth strategy following its acquisition by Advent/Corvex.

Agriculture & Natural Solutions Acquisition Corporation filed a supplement to its proxy statement, detailing updated terms for its business combination deadline extension and clarifying Investment Company Act risks.

Inland Real Estate Income Trust, Inc. announced a third-quarter 2025 distribution of $0.1356 per share, while its Board continues to review strategic alternatives amidst market volatility.

Home Federal Bancorp of Louisiana filed an amendment to its definitive proxy statement to include Inline XBRL data tagging for its insider trading policy, equity award practices, and pay versus performance disclosures.

Aimfinity Investment Corp. I seeks shareholder approval to extend its business combination deadline to July 28, 2026, and waive the net tangible asset requirement to facilitate the Docter Inc. merger.

Soluna Holdings, Inc. will hold a Special Meeting on November 7, 2025, to vote on increasing its authorized common stock from 75 million to 375 million shares.

Benitec Biopharma Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 1, 2025, to vote on director elections, auditor ratification, and executive compensation.

iSpecimen Inc. calls a special meeting to vote on a reverse stock split, authorized share increase, and new financing mechanisms to maintain Nasdaq listing and fund a digital asset treasury.

GeoVax Labs, Inc. is seeking stockholder approval for the issuance of shares related to a September 2025 private placement and a reverse stock split to maintain Nasdaq listing compliance.

INmune Bio Inc. is seeking stockholder approval to reprice certain outstanding stock options for current directors, executive officers, and employees to address retention and competitiveness concerns.

BlackRock funds update proxy statement, clarifying voting requirements for common and VRDP shareholders on proposed fund mergers.